Ogawa Shimpei, Endo Hideki, Yoshida Masahiro, Tsuru Tomomitsu, Itabashi Michio, Yamamoto Hiroyuki, Kakeji Yoshihiro, Ueno Hideki, Kitagawa Yuko, Hibi Taizo, Taketomi Akinobu, Ikeda Norihiko, Mori Masaki
The Japanese Society for Abdominal Emergency Medicine Tokyo Japan.
Department of Surgery, Institute of Gastroenterology Tokyo Women's Medical University Tokyo Japan.
Ann Gastroenterol Surg. 2024 Apr 15;8(5):795-806. doi: 10.1002/ags3.12806. eCollection 2024 Sep.
To examine the potential negative effects of the COVID-19 pandemic on short-term postoperative outcomes of emergency surgery for gastroduodenal perforation in Japan.
A total of 7973 cases of gastroduodenal perforation from 2019 to 2021 were retrieved from the National Clinical Database (NCD), which includes >95% of surgical cases in Japan. Data were analyzed nationally and in subgroups for subjects in areas with high infection levels (HILs). Postoperative 30-d mortality, surgical mortality, and complications (Clavien-Dindo (CD) grade ≥3) were examined. Months were considered to have significantly high or low mortality or complication rates, if the 95% confidence interval (CI) of the standardized mortality (morbidity) ratio (SMR) does not contain 1.
Nationally, data from 2019 vs 2020 and 2021 showed 30-d mortality of 175 (6.7%) vs 398 (7.4%), surgical mortality of 250 (9.5%) vs 537 (10.1%), and complications (CD ≥3) of 558 (21.2%) vs 1163 (21.8%). Among these data, the only significantly high SMR was found for complications in July 2020 (1.36 [95% CI: 1.001-1.80]). In areas with HILs, data from 2019 vs 2020 and 2021 indicated 30-d mortality of 91 (6.3%) vs 215 (7.3%), surgical mortality of 135 (9.4%) vs 294 (10.0%), and complications (CD ≥3) of 304 (21.1%) vs (23.1%). In these data, no month had a significantly high SMR.
The COVID-19 pandemic had few negative effects on outcomes after surgery for gastroduodenal perforation. These findings suggest that the emergency system for gastroduodenal perforation in Japan was generally maintained during the pandemic.
研究新型冠状病毒肺炎(COVID-19)大流行对日本胃十二指肠穿孔急诊手术短期术后结局的潜在负面影响。
从国家临床数据库(NCD)中检索2019年至2021年共7973例胃十二指肠穿孔病例,该数据库涵盖了日本>95%的外科病例。对全国数据以及高感染水平(HIL)地区的亚组数据进行分析。研究术后30天死亡率、手术死亡率和并发症(Clavien-Dindo(CD)分级≥3级)。如果标准化死亡率(发病率)比(SMR)的95%置信区间(CI)不包含1,则认为这些月份的死亡率或并发症发生率显著偏高或偏低。
在全国范围内,2019年与2020年及2021年的数据显示,30天死亡率分别为175例(6.7%)与398例(7.4%),手术死亡率分别为250例(9.5%)与537例(10.1%),并发症(CD≥3级)分别为558例(21.2%)与1163例(21.8%)。在这些数据中,仅发现2020年7月并发症的SMR显著偏高(1.36[95%CI:1.001-1.80])。在HIL地区,2019年与2020年及2021年的数据表明,30天死亡率分别为91例(6.3%)与215例(7.3%),手术死亡率分别为135例(9.4%)与294例(10.0%),并发症(CD≥3级)分别为304例(21.1%)与(23.1%)。在这些数据中,没有哪个月份的SMR显著偏高。
COVID-19大流行对胃十二指肠穿孔手术后的结局几乎没有负面影响。这些发现表明,日本胃十二指肠穿孔的急诊系统在大流行期间总体上得以维持。